Conventional Oncology Products
Weembrace Biopharma is a rapidly growing oncology-focused pharmaceutical company in India, committed to advancing patient care through innovation and quality. We develop and market a comprehensive range of oncology products—from generic cancer therapies to advanced formulations designed to support better treatment outcomes.
With a robust manufacturing and marketing infrastructure, Weembrace Biopharma ensures global-standard quality in every product. Our portfolio also includes innovative collaborations that aim to address unmet clinical needs, supporting improved access to cancer care.
| Brand Name | Molecule | Therapy | Dosage Form | Packing | Package Insert |
|---|---|---|---|---|---|
| CARBOWEMB 150 MG INJ 450 MG INJ 600 MG INJ |
Carboplatin | Anti-neoplastic | Vial | 1X150 mg1X450 mg1X600 mg |
Download PDF (150MG, 450 MG) Download PDF (600 MG) |
| DOCE-ACE 120 MG / 80 MG / 20 MG | Docetaxel | Anti-neoplastic | Vial | 1X120 mg1X80 mg1X20 mg |
Download PDF |
| GEMWEM RTU 1 GM / 200 MG | Gemcitabine Hydrochloride | Anti-neoplastic | Vial | 1X1 gm1X200 mg |
Download PDF |
| IFOWEM 1GM INJ / 2GM INJ | IFOSFAMIDE with Mesna (100Mg) injection | Anti-neoplastic | Vial | 1x1 gm1X2 mg |
Download PDF |
| WEMPACLI 100 MG / 260 MG / 30MG | Paclitaxel | Anti-Neoplastic | Vial | 1X100 mg1X260 mg1X30 mg |
Download PDF |
| XELODACE 500 MG | Capecitabine | Anti-Neoplastic | Tablet | 1X10's |
Download PDF |
| ASPARAWEM 5000IU | L-Asparaginase | Anti-neoplastic | Vial | 1X5000 IU |
Download PDF |
| WEBACE 75MG / 100 MG / 125 MG | Palbociclib | Targeted Therapy | Capsule | 1X7x3's |
Download PDF |
| LTROMB 25 MG / 50 MG | Eltrombopag | Platelet-stimulating agent | Tablet | 1X7's |
Download PDF |
| MEGA-ACE 160MG | Megestrol acetate | Anti-neoplastic | Tablet | 1×10's |
|
| WEMTANIB 250MG | Lapatinib | Anti-neoplastic | Tablet | 1×30's |
*Disclaimer: The information provided on this page is intended for informational purposes only and should not be construed as medical advice, diagnosis, or treatment recommendation. Users are advised to consult qualified healthcare professionals where applicable.